Your search returned 13 results.

Sort
Results
1.
Safety and Efficacy of First-Line Pembrolizumab in Black Patients with Metastatic Non-Small Cell Lung Cancer. MedStar authors:
  • Chen, Kevin
  • Kim, Chul
  • Peravali, Monica
  • Rao, Suman
  • Veytsman, Irina
PMID:
  • 33844354
Year: 2021
Citation:
  • Oncologist. 26(8):694-700, 2021 08.
Institution:
  • MedStar Franklin Square Medical Center
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Hematology/Oncology Fellowship
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Ahn J, Chen K, Kim C, Liu SV, Peravali M, Rao S, Veytsman I
2.
Linear IgA Disease of the Gingiva Following Nivolumab Therapy. MedStar authors:
  • DeKlotz, Timothy R
  • Khan, Amir
PMID:
  • 31246639
Year: 2019
Citation:
  • Journal of Immunotherapy. 42(9):345-347, 2019 Nov/Dec.
Institution:
  • MedStar St Mary's Hospital
  • MedStar Washington Hospital Center
Department:
  • Otolaryngology
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • DeKlotz T, Gibney GT, Jonna S, Khan A, Lakshmanan S, Lanasa D, Liu SV, Neiders M
3.
Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis. MedStar authors:
  • Barac, Ana
  • Forrestal, Brian J
PMID:
  • 32029128
Year: 2020
Citation:
  • Journal of the American College of Cardiology. 75(5):467-478, 2020 02 11.
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Alvi RM, Awadalla M, Bakar RB, Banerji D, Barac A, Chen CL, Cohen JV, Devereux RB, Ederhy S, Forrestal BJ, Fradley MG, Ganatra S, Groarke JD, Gupta D, Hassan MZO, Heinzerling LM, Hung J, Jones-O'Connor M, Kirchberger MC, Lawrence DP, Liu S, Lyon AR, Mahmood SS, Mahmoudi M, Mandawat A, Mercaldo ND, Mulligan CP, Murphy SP, Neilan TG, Nohria A, Picard MH, Reynolds KL, Rizvi MA, Rokicki A, Sahni G, Shah SP, Sullivan RJ, Thavendiranathan P, Thuny F, Tocchetti CG, Zhang L, Zlotoff DA
4.
Combined Inhibition of EGFR and VEGF Pathways in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis. [Review] MedStar authors:
  • Kim, Chul
  • Peravali, Monica
  • Veytsman, Irina
  • Wang, Haijun
PMID:
  • 32945977
Year: 2020
Citation:
  • Current Oncology Reports. 22(12):119, 2020 09 18.
Institution:
  • MedStar Health Research Institute
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Hematology and Oncology
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Kim C, Peravali M, Veytsman I, Wang H
5.
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score >= 50. MedStar authors:
  • Rao, Suman
PMID:
  • 33872070
Year: 2021
Citation:
  • Journal of Clinical Oncology. 39(21):2339-2349, 2021 07 20.
Institution:
  • MedStar Franklin Square Medical Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, Jensen E, Leal TA, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riess JW, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhao B
6.
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium. MedStar authors:
  • Arora, Aakriti
PMID:
  • 37192435
Year: 2023
Citation:
  • Journal of Clinical Oncology. 41(21):3712-3723, 2023 07 20.
Institution:
  • MedStar Washington Hospital Center
Department:
  • Internal Medicine Residency
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Abdallah W, Abdel-Wahab N, Aboubakar Nana F, Abu Ghazal B, Addeo A, Adib E, Al-Hader A, Arora A, Baden LR, Baena J, Bahary N, Baiocchi RA, Bakalov V, Bankapur A, Barletta G, Bersanelli M, Bower M, Chiao EY, Choueiri TK, Cortellini A, Dalla Pria A, Diab A, Dima D, Dittus C, Dizman N, Dobbs RW, Drakaki A, Drolen C, El Zarif T, El-Am E, Emu B, Falohun A, Fitzgerald BG, Florou V, Freeman D, Funchain P, Genova C, Hall E, Haykal T, Huang J, Idossa D, Johnson DB, Kim C, Kozaily E, Lamberti G, Lechner MG, Li M, Long GV, Lopetegui-Lia N, Lorentsen M, Lurain K, Mangla A, Marron TU, McKay RR, Menzies AM, Mittra A, Morse MA, Mouhieddine TH, Naqash AR, Nassar AH, Nebhan CA, Nonato T, Owen DH, Pinato DJ, Puri S, Queirolo P, Rajkumar A, Ramaswami R, Reed A, Reid EG, Rubinstein PG, Saeed A, Saleem R, Saponara M, Shah NJ, Shah V, Sharon E, Singh P, Sonpavde GP, Woodford R, Xie W
7.
Obatoclax mesylate, a pan-bcl-2 inhibitor, in combination with docetaxel in a phase 1/2 trial in relapsed non-small-cell lung cancer. MedStar authors:
  • Van Echo, David A
PMID:
  • 24346101
Year: 2014
Citation:
  • Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer. 9(1):121-5, 2014 Jan.
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Clinical Trial, Phase I
  • Clinical Trial, Phase II
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Adams JW, Berger MS, Chiappori A, Edelman MJ, Haura EB, Malik S, Northfelt DW, Rosen P, Van Echo DA, Williams C
8.
Management of Malignant Peritoneal Mesothelioma Using Cytoreductive Surgery and Perioperative Chemotherapy. MedStar authors:
  • Sugarbaker, Paul H
PMID:
  • 27858561
Year: 2016
Citation:
  • Journal of oncology practice/American Society of Clinical Oncology. 12(10):928-935, 2016 Oct
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Alexander HR Jr, Deraco M, Hesdorffer M, Sugarbaker PH, Turaga KK
9.
Role of Anti-EGFR Targeted Therapies in Stage III Locally Advanced Non-small Cell Lung Cancer: Give or Not to Give?. [Review] MedStar authors:
  • Desai, Sanjal
  • Kim, Chul
  • Veytsman, Irina
PMID:
  • 31410582
Year: 2019
Citation:
  • Current Oncology Reports. 21(9):84, 2019 08 13.
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Desai S, Kim C, Veytsman I
10.
Real-world survival outcomes with immune checkpoint inhibitors in large-cell neuroendocrine tumors of lung. MedStar authors:
  • Kareff, Samuel
  • Kim, Chul
PMID:
  • 33597218
Year: 2021
Citation:
  • Journal for Immunotherapy of Cancer. 9(2), 2021 02.
Institution:
  • MedStar Washington Hospital Center
  • Washington Cancer Institute
Department:
  • Medicine/Internal Medicine
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Bar J, Dudnik E, Gottfried T, Israel Lung Cancer Group, Kareff S, Kim C, Liu SV, Lobachov A, Moskovitz M, Onn A, Rotem O, Urban D, Wollner M, Zer A
11.
Phase 2 clinical trial of sunitinib as adjunctive treatment in patients with advanced differentiated thyroid cancer. MedStar authors:
  • Barett, Christina
  • Bikas, Athanasios
  • Burman, Kenneth D
  • Clark, Brandon G
  • Desale, Sameer
  • Gandhi, Rahul
  • Jelinek, James S
  • Kundra, Priya
  • Mete, Mihriye
  • O'Keefe, Kaitlyn
  • Wartofsky, Leonard
  • Wexler, Jason
  • Wray, Lynette
PMID:
  • 26671977
Year: 2016
Citation:
  • European Journal of Endocrinology. 174(3):373-80, 2016 Mar.
Institution:
  • MedStar Health Research Institute
  • MedStar Heart & Vascular Institute
  • MedStar Washington Hospital Center
Department:
  • Medicine/Endocrinology
  • Radiology
Medline publication type:
  • Clinical Trial, Phase II
  • Journal Article
  • Research Support, Non-U.S. Gov't
Form of publication:
  • Journal Article
All authors:
  • Barett C, Bikas A, Burman KD, Clark BG, Desale S, Gandhi R, Jelinek JS, Kundra P, Mete M, O'Keefe K, Wartofsky L, Wexler JA, Wray L
12.
Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial. MedStar authors:
  • Rao, Suman
PMID:
  • 29129441
Year: 2017
Citation:
  • Lancet Oncology. 18(12):1600-1609, 2017 Dec
Institution:
  • MedStar Franklin Square Hospital
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Deitz AC, Fulop A, Gottfried M, Hotta K, Hui R, Lubiniecki GM, O'Brien M, Peled N, Rangwala R, Rao S, Reck M, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Zhang J
13.
Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater. MedStar authors:
  • Rao, Suman
PMID:
  • 30620668
Year: 2019
Citation:
  • Journal of Clinical Oncology. 37(7):537-546, 2019 03 01.
Institution:
  • Medstar Franklin Square Medical Center
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Brahmer JR, Csoszi T, Cuffe S, Fulop A, Gottfried M, Hotta K, Hui R, O'Brien M, Peled N, Pietanza MC, Rao S, Reck M, Riccio A, Robinson AG, Rodriguez-Abreu D, Tafreshi A, Vandormael K, Yang J
Pages

Powered by Koha